These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 8756928)
21. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy. Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661 [TBL] [Abstract][Full Text] [Related]
22. Lacrimal system obstruction treated with lacrimal polyurethane stents: outcome of removal of occluded stents. Song HY; Lee DH; Ahn H; Kim JH; Kang SG; Yoon HK; Sung KB Radiology; 1998 Sep; 208(3):689-94. PubMed ID: 9722847 [TBL] [Abstract][Full Text] [Related]
23. Resolution of epiphora with nasolacrimal stents: results of long-term follow-up in a multicenter prospective study. Lanciego C; Toledano N; De Miguel S; Perea M; Padilla M; Rodriguez-Merlo R; Dávila J; Ibarburen C; Cano C; García IR; García LG J Vasc Interv Radiol; 2003 Nov; 14(11):1417-25. PubMed ID: 14605107 [TBL] [Abstract][Full Text] [Related]
24. Nasolacrimal stents in the management of epiphora: medium-term results of a multicenter prospective study. Lanciego C; De Miguel S; Perea M; Cano C; García IR; Dávila J; Ibarburen C; Toledano N; Rodriguez-Merlo R; García LG J Vasc Interv Radiol; 2001 Jun; 12(6):701-10. PubMed ID: 11389221 [TBL] [Abstract][Full Text] [Related]
25. [Lacrimal duct stent for nasolacrimal duct obstruction]. Xiao M; Jiang Y; Zhang Z Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):289-91. PubMed ID: 12133376 [TBL] [Abstract][Full Text] [Related]
27. Clinical effectiveness of balloon dacryocystoplasty in circumscribed obstructions of the nasolacrimal duct. Lüchtenberg M; Bartel JH; Bink A; Kuhli-Hattenbach C; Berkefeld J Ophthalmologica; 2007; 221(6):434-8. PubMed ID: 17947834 [TBL] [Abstract][Full Text] [Related]
28. [Nasolacrimal stent for epiphora caused by obstruction of the nasolacrimal duct]. Posthuma BJ; van Imhoff WL; van Wezer JE Ned Tijdschr Geneeskd; 1997 Feb; 141(7):339-41. PubMed ID: 9132609 [TBL] [Abstract][Full Text] [Related]
29. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications. Schaudig U; Maas R Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340 [TBL] [Abstract][Full Text] [Related]
30. [A comparative study of lacrimal magnetic resonance hydrography and lacrimal endoscopy examination in the diagnosis and treatment of lacrimal duct obstructive diseases]. Xiang N; Liu R; Zhang SJ; Hu WK; Zhan XY; Luo B; Ai T Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):117-22. PubMed ID: 26906707 [TBL] [Abstract][Full Text] [Related]
31. [Site of a polyurethane stent in dacryocystography. Is postoperative success hereby predictable?]. Anders N; Hoffmann KT Ophthalmologe; 2000 Dec; 97(12):842-5. PubMed ID: 11227155 [TBL] [Abstract][Full Text] [Related]
32. Dacryocystoplasty: treatment of epiphora by means of balloon dilation of the obstructed nasolacrimal duct system. Janssen AG; Mansour K; Krabbe GJ; van der Veen S; Helder AH Radiology; 1994 Nov; 193(2):453-6. PubMed ID: 7972762 [TBL] [Abstract][Full Text] [Related]
33. Obstruction of the lacrimal system: treatment with a covered, retrievable, expandable nitinol stent versus a lacrimal polyurethane stent. Ko GY; Song HY; Seo TS; Kim TH; Sung KB; Yoon HK Radiology; 2003 Apr; 227(1):270-6. PubMed ID: 12616010 [TBL] [Abstract][Full Text] [Related]
34. Silicone intubation for the treatment of epiphora in adults with presumed functional nasolacrimal duct obstruction. Moscato EE; Dolmetsch AM; Silkiss RZ; Seiff SR Ophthalmic Plast Reconstr Surg; 2012; 28(1):35-9. PubMed ID: 22262288 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic findings after nasolacrimal polyurethane stent implantations. Lee JH; Kang MS; Yang JW Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813 [TBL] [Abstract][Full Text] [Related]
36. [Application value of computed tomography dacryocystography in children lacrimal diseases]. Yu G; Zhang CY; Cui YH; Fan YW; Cao WH; Lin Q; Qi Y; Cui J; Hu M; Liu W; Wu Q Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):706-10. PubMed ID: 24246809 [TBL] [Abstract][Full Text] [Related]
37. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience. Pulido-Duque JM; Reyes R; Carreira JM; Vega F; Górriz E; Pardo MD; Perez F; Maynar M Cardiovasc Intervent Radiol; 1998; 21(1):41-4. PubMed ID: 9473545 [TBL] [Abstract][Full Text] [Related]
38. [Balloon dilatation and Stentimplantation of the nasolacrimal duct for chronic epiphora]. Lachmund U; Ammann-Rauch D; Forrer A; Grob M; Petralli C; Remonda L; Roeren T; Wilhelm K Ophthalmologe; 2005 Apr; 102(4):375-86. PubMed ID: 15599560 [TBL] [Abstract][Full Text] [Related]
39. Obstructed nasolacrimal duct system in epiphora: long-term results of dacryocystoplasty by means of balloon dilation. Janssen AG; Mansour K; Bos JJ Radiology; 1997 Dec; 205(3):791-6. PubMed ID: 9393537 [TBL] [Abstract][Full Text] [Related]
40. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing? Oztürk S; Konuk O; Ilgit ET; Unal M; Erdem O Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):130-5. PubMed ID: 15083082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]